Americans: Cloning
By YouGov,
YouGov
| 01. 26. 2013
In this YouGov poll, the questions are:
1. Suppose it were possible to clone a woolly mammoth (an extinct relative of modern elephants). Should scientists be allowed to clone them?
2. Suppose it were possible to clone a Neanderthal (an extinct close cousin of modern humans). Should scientists be allowed to clone them?
3. Suppose it were possible to clone a Neanderthal, but it would require a human volunteer to be a surrogate mother to the Neanderthal. Should scientists be allowed to clone them?
4. Do you think scientists should be allowed to try to clone human beings?
| |
Yes |
No |
Not sure |
| Cloning mammoth |
31 |
46 |
23 |
| Cloning Neanderthal |
17 |
63 |
20 |
| Cloning Neanderthal w/human surrogate |
15 |
66 |
18 |
| Cloning humans |
16 |
66 |
18 |
- 1,000 American adults
- conducted January 25–26, 2013
- margin of error is 3.7%
- Source: YouGov Omnibus Poll [described here]
Related Articles
By Virginia Heffernan, The New Republic | 05.29.2026
Here and there, it’s been a good month for humanity—or “magnificas humanitas,” as Pope Leo XIV calls us poor featherless bipeds.
On May 25, the pope published his encyclical letter “on safeguarding the human person in the time of artificial...
By Sonya Borrero, Christine Dehlendorf, and Rachel Logan, Stat | 05.01.2026
America is worried about fertility rates — again.
Coverage of the country’s declining birth rate reflects widespread unease: Families are struggling, young adults are delaying or forgoing parenthood, and the future labor force feels uncertain. These concerns are rooted in...
By Emile P. Torres, Truthdig | 04.27.2026
The CEO of OpenAI, Sam Altman, is on a messianic mission to bring about the singularity, the moment at which artificial intelligence begins to self-improve. If AI is smart enough to build the next generation of even smarter AI...
By Marcelo Jauregui-Volpe, Wired | 04.24.2026
Two companies that launched last year with plans to create gene-edited babies have already shut down, citing money issues and internal conflict.
One of them, Manhattan Genomics of New York, closed abruptly shortly after announcing a team of scientific advisers...